Oklo 2Q Loss Widens on Costs, R&D Ramping Up

Dow Jones
08/07
 
 

Oklo's loss widened in the second quarter as the company stepped up research-and-development spending and expanded its engineering and regulatory teams.

The advanced nuclear technology startup on Friday posted a widened net loss of $48.5 million, or 28 cents a share, compared with a loss of $24.7 million, or 18 cents a share, in the same quarter a year ago.

The loss widened on the back of higher research and development costs and expenses related to expanding its engineering teams and regulatory efforts.

Oklo maintained a large reserve of liquidity, and held cash, cash equivalents and marketable debt securities of $3.01 billion at quarter's end.

Revenue was $1.2 million in the quarter, compared with zero.

Oklo is working toward commercializing its metal-fueled fast reactor technology with the Aurora powerhouse product line. The company expects the line to produce between 15 and 75 megawatts of electricity on fresh, recycled or down-blended nuclear fuel, to supply clean power directly to data centers and industrial sites, while pioneering domestic fuel recycling and radioisotope production.

The company is backed by OpenAI chief executive, Sam Altman, and was the first to secure a U.S. Department of Energy site permit for a commercial advanced plant and has secured fuel allocation from the Idaho National Laboratory.

Altman was the company's chairman before stepping down from the role in mid-2025.

Oklo remains in a pre-revenue development stage, with its first commercial powerhouse targeted to go online in 2028.

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10